A big step forward in COVID-19 treatment and a breakthrough for a Florida-based nonprofit blood center serving the southeast. OneBlood just became the first blood center to get full FDA approval to ...

The Trump administration's "short pause" on communications, expected to end on Feb. 1, has affected FDA updates on food ...

Federal regulators have warned a Waco company that its human amniotic products are “unlicensed” and “unapproved,” and that ...

One strategy antiabortion advocates may increasingly rely upon as they attempt to block medication abortion from reaching ...

WASHINGTON (AP) — When President Donald Trump tapped Robert F. Kennedy Jr. to become the nation’s top health official, his ...

The Centers for Disease Control and Prevention is going dark, along with other federal agencies within the umbrella of the ...

The QuickFinder COVID-19/Flu Antigen Self-Test and the QuickFinder COVID-19/Flu Antigen Pro Test detect SARS-CoV-2, influenza A, and influenza B in swab specimens and provide results within 15 minutes ...

Despite long COVID’s vast reach, and more than $1 billion spent on research, no new treatments have been brought to market.

A Belgian court dismissed a lawsuit against EU chief Ursula von der Leyen centered on text messages she exchanged with Pfizer ...

Johnson & Johnson executives, on a Wednesday earnings call, did not provide a timeline for when U.S. Varipulse cases will ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.